NCT03614533View on ClinicalTrials.gov

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

PHASE2CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

August 22, 2019

Study Completion Date

August 22, 2024

Conditions
Typhoid
Interventions
BIOLOGICAL

Vi-Typhoid Conjugate Vaccine (Vi-TCV)

Single 0.5-ml intramuscular injection

BIOLOGICAL

Inactivated Poliovirus Vaccine (IPV)

Single 0.5-ml intramuscular injection

Trial Locations (1)

Unknown

Groupe de Recherche Action en Santé (GRAS), Ouagadougou

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Groupe de Recherche Action en Sante

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT03614533 - Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso | Biotech Hunter | Biotech Hunter